Walter Frankmoelle

Title: Walter Frankmoelle: Innovator in Tubulin-Binding Agents

Introduction

Walter Frankmoelle is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target tubulin. His innovative work has led to the creation of a patent that holds promise for advancing cancer treatment.

Latest Patents

Walter Frankmoelle holds a patent for "Certain polycyclic compounds useful as tubulin-binding agents." This patent describes derivatives of known tubulin-binding compounds that incorporate (poly)fluorobenzene, fluoropyridine, or fluoronitrobenzene moieties. These derivatives are designed to function as antimitotic agents and act as covalent modifiers of tubulin. The strategy for developing these compounds includes appending fluorinated electrophiles to existing functional groups, replacing aromatic rings with fluorinated electrophiles, and attaching these electrophiles to open valences in a manner that does not interfere with tubulin binding.

Career Highlights

Walter Frankmoelle has made a significant impact in his field through his work at Tularik Limited. His research focuses on creating effective antimitotic agents that can potentially improve cancer therapies. His innovative approach to modifying existing compounds has opened new avenues for drug development.

Collaborations

Walter has collaborated with esteemed colleagues such as David Louis Clark and Jonathan B Houze. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Walter Frankmoelle's contributions to the field of medicinal chemistry, particularly through his patent on tubulin-binding agents, highlight his role as an innovator. His work continues to influence the development of new therapeutic strategies in cancer treatment.